Research Site
Alderley Park, Cheshire, United Kingdom
NCT Number: NCT00853983
The aim of this study is to show how the body absorbs, metabolises and excretes the drug [14C]AZD0530. As for all clinical trials, safety and tolerability of the drug will be evaluated.
Looking for future studies?
Notify Me50 year and older
Male
Interventional
Phase 1
Alderley Park, Cheshire, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Solution, Oral, once
Time frame: Multiple PK, Urine and faeces samples taken between predose to 240 hours post dose
Time frame: From time of consent to last visit
AstraZeneca
Industry
An Open-Label, Phase I Study to Assess Absorption, Metabolism and Excretion of a Single Oral Dose of [14C]AZD0530 in Healthy Male Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06840925
Healthy
Melbourne, Victoria, Australia
View Trial DetailsNCT01866852
Healthy
Bethesda, Maryland, United States
View Trial DetailsNCT05370222
Behavior, Behavior, Animal
Clermont-Ferrand, AURA, France
View Trial DetailsNCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial Details